홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

설파살라진

Sulfasalazine

HCID 5339
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
599-79-1
표준 SMILES
O=C(O)c1cc(N=Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O
InChIKey
NCEXYHBECQHGNR-UHFFFAOYSA-N
분자식
C18H14N4O5S
평균 분자량
398.4 g/mol
단동위원소 질량
398.06849055

개요

Sulfasalazine (salicylazosulfapyridine) can cause cancer according to The National Toxicology Program. It can cause male reproductive toxicity according to state or federal government labeling requirements.

이름 및 식별자

우선 이름
Sulfasalazine
IUPAC
2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid
현지명
설파살라진
영어명
Sulfasalazine
분자식
C18H14N4O5S
분자량
398.39

이름 및 동의어

sulfasalazine599-79-1SalicylazosulfapyridineSulphasalazineAzulfidineSalazosulfapyridineSalazopyrinBenzosulfaSulcolonSalazopyridinAsulfidineAzopyrine
이름 더 보기
설파살라진saspsulfasalazinSSZs.a.s.-500si-88
AccucolAzopyrinSalisulfSalazopiridazinReupirinw-t Sasp oralColo-PleonSalazosulfapyridin

데이터베이스 식별자

CAS
599-79-1
PubChem CID
5339
DTXSID
DTXSID0021256
ChEMBL
CHEMBL100848、CHEMBL242373
ChEBI
CHEBI:9334
UNII
3XC8GUZ6CB
Nikkaji
J2.073G

물성

구조 계산 물성

XLogP
-0.7
극성 표면적
150 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
9
회전 가능 결합 수
6
무거운 원자 수
28
형식 전하
0
복잡도
657

실험 및 물리화학적 성질

Drugs · 4건

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Analgesics and anti-inflammatories

Pharmaceuticals -> Listed in ZINC15

LogP-0.13
SolubilityPractically insoluble in water
Dissociation Constants · 2건

2.65

0.6

Collision Cross Section · 4건

203.9 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID0021256]

199.36 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

200.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

199.7 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

물리화학적 성질

녹는점
260 · 260-265 °C (dec.)(lit.)
끓는 점
689.3 · 689.3±65.0 °C(Predicted)
밀도
1.3742 · 1.3742 (rough estimate)
굴절률
1.6 · 1.6000 (estimate)
저장 조건
Keep in dark place,Sealed in dry,Room Temperature
용해도
4 OH · NH4OH 1 M: 50 mg/mL, 투명, 빨간색
산도 계수 (pKa)
0.6 · pKa 0.6(H2O t = 20 I < 0.001) (Uncertain);2.4(H2O t = 20 I < 0.001) (Uncertain);9.7(H2O t = 20 I < 0.001) (Uncertain);11.8(H2O t = 20 I < 0.001) (Uncertain)
물리적 상태
가루
색상
오렌지 레드
수용성
25 · 25 ºC에서 <0.1g/100mL
Merck
14 · 14,8942
BRN
356241 · 356241
BCS Class
2 · 2,4
안정성
1 · 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO의 솔루션은 최대 1개월 동안 -20°에서 보관할 수 있습니다.
주요 응용
법의학 및 독성학의약품(소분자)
InChI
1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+
InChIKey
NCEXYHBECQHGNR-QZQOTICOSA-N
SMILES
OC(=O)c1cc(ccc1O)\N=N\c2ccc(cc2)S(=O)(=O)Nc3ccccn3
EPA
Salicylazosulfapyridine (599-79-1)

화학적 성질

Brownish-Yellow Crystals

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

EPA Human Health Benchmarks for Pharmaceuticals · 6건

Sulfasalazine

46.6

197.2

Maintenance therapy dosage for adults is 2 g daily.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 2000 mg/day, Lowest Therapeutic Dose (LTD): 25.0 mg/kg-day, and Screening Dose: 0.008 mg/kg-day.

10-Feb-21

안전 데이터

wgk
2
rtecs
VO6250000
ridadr
3077
독성
LD50 oral in rabbit: > 7500mg/kg
HS 번호
2933399090
risk_code
42/43
hazard_code
Xn
safety_code
22-29/56-45
F 고인화성물질
8
Hazard Classifications
Aquatic Chronic 2Carc. 2Repr. 2Resp. Sens. 1Skin Sens. 1
스토리지 클래스
11 - Combustible Solids
유해 물질 데이터
599-79-1(Hazardous Substances Data)

화학 및 산업

약리 정보

ATC CodeA07EC01
Protein BindingSulfasalazine is highly bound to albumin (>99.3%) while sulfapyridine is only about 70% bound to albumin. Acetylsulfapyridine, the principal metabolite of sulfapyridine, is approximately 90% bound to plasma proteins.
Pharmacodynamics · 1건

The mode of action of sulfasalazine or its metabolites, 5-aminosalicylic acid and sulfapyridine, is still under investigation but may be related to the anti-inflammatory and/or immunomodulatory properties that have been observed in animal and <i>in vitro</i> models, to its affinity for connective tissue, and/or to the relatively high concentration it reaches in serous fluids, the liver, and intestinal walls, as demonstrated in autoradiographic studies in animals. In ulcerative colitis, clinical studies utilizing rectal administration of sulfasalazine, sulfapyridine, and 5-aminosalicylic acid have indicated that the major therapeutic action may reside in the 5-aminosalicylic acid moiety. The relative contribution of the parent drug and the major metabolites in rheumatoid arthritis is unknown.

Mechanism of Action · 1건

Although the exact mechanism of action of sulfasalazine is not fully understood, it is thought to be mediated through the inhibition of various inflammatory molecules. Research have found that sulfasalazine and its metabolites, mesalazine and sulfapyridine, can inhibit leukotrienes and prostaglandins by blocking the cyclo-oxygenase and lipoxygenase pathway. Specific enzymes that were investigated include phospholipase A2, cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX2), and arachidonate 5-lipoxygenase. Inhibitory activities on other non-arachidonic acid derivatives have also been observed, including PPAR gamma, NF-Kb, and IkappaB kinases alpha and beta.

Biological Half-Life · 1건

The observed plasma half-life for intravenous sulfasalazine is 7.6 ± 3.4 hours.In fast acetylators, the mean plasma half-life of sulfapyridine is 10.4 hours while in slow acetylators, it is 14.8 hours.Due to low plasma levels produced by 5-aminosalicylic acid after oral administration, reliable estimates of plasma half-life are not possible.

Metabolism/Metabolites · 1건

In the intestine, sulfasalazine is metabolized by intestinal bacteria to sulfapyridine and 5-aminosalicylic acid. Of the two species, sulfapyridine is relatively well absorbed from the intestine and highly metabolized, while 5-aminosalicylic acid is much less well absorbed.Approximately 15% of a dose of sulfasalazine is absorbed as the parent drug and is metabolized to some extent in the liver to the same two species.Sulfapyridine can also be metabolized to 5-hydroxysulfapyridine and N-acetyl-5-hydroxy sulfapyridine. 5-aminosalicylic acid is primarily metabolized in both the liver and intestine to N-acetyl-5 aminosalicylic acid via a non-acetylation phenotype-dependent route.

Absorption, Distribution and Excretion · 4건

Following oral administration of 1 g of sulfasalazine to 9 healthy males, less than 15% of a dose of sulfasalazine is absorbed as the parent drug. Detectable serum concentrations of sulfasalazine have been found in healthy subjects within 90 minutes after ingestion. Maximum concentrations of sulfasalazine occur between 3 and 12 hours post-ingestion, with the mean peak concentration (6 μg/mL) occurring at 6 hours.

Absorbed sulfapyridine and 5-aminosalicylic acid and their metabolites are primarily eliminated in the urine either as free metabolites or as glucuronide conjugates. The majority of 5-ASA stays within the colonic lumen and is excreted as 5-aminosalicylic acid and acetyl-5-aminosalicylic acid in the feces.

Following intravenous injection, the calculated volume of distribution for sulfasalazine was 7.5 ± 1.6 L.

The calculated clearance of sulfasalazine following intravenous administration was 1 L/hr. Renal clearance was estimated to account for 37% of total clearance.

응용 분야 · 3건

개요Sulfasalazine (brand name Azulfidine in the U.S., Salazopyrin and Sulazine in Europe and Hong Kong) was developed in the 1950s specifically to treat rheumatoid arthritis. It was believed at the time that bacterial infections were the cause of rheumatoid arthritis. Sulfasalazine is a sulfa drug, (a derivative of mesalazine) and is formed by combining sulfa pyridine and salicylate with an azo bond. It may be abbreviated SSZ.

용도Sulfasalazine is an anti-inflammatory (gastrointestinal). Sulfasalazine has been used in granulomatous colitis.

일반 설명Odorless yellow or brownish-yellow to orange powder. Tasteless.

상·하류 제품 정보

상류 원료

벤젠술포닐클로라이드아세트산(빙초산)2-아미노피리딘설파피리딘아세트아닐리드5-아미노셀릭일 산4-Nitroso-N-2-pyridinylbenzenesulfonamide살리실산4-(아세틸아미노)벤젠설포닐 클로라이드수산화나트륨

추가 설명

정의ChEBI: An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

관련 반응

4건
반응 기록 만들기
HRID 1750338 반응식
HRID 1750338반응물로
HRID 2202207 반응식
HRID 2202207반응물로
HRID 2205960 반응식
HRID 2205960반응물로
HRID 2272552 반응식
HRID 2272552반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트